It is a great pleasure to warmly invite you to participate in the upcoming 2nd International Congress on Clinical Trials on Cannabis (CT-Cann2023), which will take place 15-16 February 2023 in London, UK.
It has been a long and eventful nearly 3 years since CT-Cann2019, and our hopes of meeting again had to be put on hold. It is a joy that we are finally able to hold CT-Cann2023 while adhering to health guidance that will ensure a safe event for all of us.
Despite the understandable focus on COVID related research in the last two plus years, the therapeutic implications of cannabinoids has also remained an intense interest of study yielding new discoveries and a deeper understanding…
Medical Cannabis Clinicians Society and UK Cannabis Industry Council, UK
Imperial College Healthcare NHS Trust, UK
Institute for Pain Medicine, Tel Aviv Medical Center, Israel
Pain Relief Unit, Hadassah Hebrew University Medical Center, Israel
University of Galway, Ireland
Faculty of Biology, Technion Israel Institute of Technology, Israel
Division of Brain Sciences. Imperial College London, UK
Sagol Brain Institute and Institute of Pain Medicine Tel Aviv Medical Center and Sackler Faculty of Medicine, Israel. President of the Israel Pain Association
Engredo ApS, Denmark
Early Registration deadline: 21/12/22
Submission deadline: 9/1/23
We look forward to hearing from you.